19-12-2021 / Daniela van 't Ent - Ifrim / Legislation
If you have missed the EMA webiner from 29NOV2021 regaridng the upcoming CTIS, there is still a chance to acces the slides on EMA wesbite, here.
The scope of the webinar was to inform pharmaceutical companies and academic sponsors of clinical…
13-10-2020 / Daniela van 't Ent - Ifrim / Branche
Starting with 19th of October 2020, Marketing Authorization Holders of human and veterinary medicines should use EMA’s IRIS Regulatory & Scientific Information Management Platform in order to request scientific advice regarding the study design.
The following type information may be requested via IRIS:
16-09-2020 / Daniela van 't Ent - Ifrim / Legislation
UK’s Health Research Authority new initiative is to reach 100% of clinical trials registration, including CT results, into the public database. This is in order to offer transparency regarding clinical trials and facilitate information sharing among the researchers.
This strategy:
03-09-2020 / Daniela van 't Ent - Ifrim / Branche
MHRA has just issued guidance regarding post Brexit period and clinical trials, devices, licensing, importing and exporting, IT systems, pharmacovigilance and paediatrics.
27-08-2020 / Daniela van 't Ent - Ifrim / Legislation
TranspariMED and Health Action International (HAI) have recently reported that Dutch institutions that run clinical trials violate the European transparency rules but failing to report clinical trials results in the public registry.
Only 1 out of 23 universities/research institutes has adequately…